Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Gains 4%; BSE HEALTHCARE Index Up 0.3%
Thu, 24 Oct 9:46

PIRAMAL PHARMA Gains 4%; BSE HEALTHCARE Index Up 0.3%Image source: DNY59/www.istockphoto.com

PIRAMAL PHARMA share price has zoomed 4% and is presently trading at Rs 225.8.

Meanwhile, the BSE HEALTHCARE index is at 42,818.4 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are ASTER DM HEALTHCARE (up 12.1%) and SYNGENE INTERNATIONAL (up 3.5%).

DR. LAL PATHLABS (down 2.5%) and Pfizer (down 1.5%) are among the top losers today.

Over the last one year, PIRAMAL PHARMA has moved up from Rs 93.8 to Rs 225.8, registering a gain of Rs 132.0 (up 140.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,503.7 to 42,818.4, registering a gain of 55.7% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 213.8%), Glenmark Pharma (up 121.2%) and SUVEN PHARMACEUTICALS (up 119.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,927.4 (down 0.2%).

The top losers among the BSE Sensex today are Hindustan Unilever (down 5.1%) and Nestle (down 1.5%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,362.2 (down 0.3%). Hindustan Unilever and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 79,927.4, registering a gain of 15,355.5 points (up 23.8%).

PIRAMAL PHARMA Financial Update...

PIRAMAL PHARMA net profit grew 137.8% YoY to Rs 53 million for the quarter ended September 2024, compared to a loss of Rs 141 million a year ago. Net sales rose 17.3% to Rs 22,418 million during the period as against Rs 19,114 million in July-September 2023.

For the year ended March 2024, PIRAMAL PHARMA reported 109.6% increase in net profit to Rs 178 million compared to net loss of Rs 1,865 million during FY23. Revenue of the company grew 15.4% to Rs 81,712 million during FY24.

The current Price to earnings ratio of PIRAMAL PHARMA, based on rolling 12 month earnings, stands at -1473.9.


Equitymaster requests your view! Post a comment on "PIRAMAL PHARMA Gains 4%; BSE HEALTHCARE Index Up 0.3%". Click here!